Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3979715
Max Phase: Preclinical
Molecular Formula: C22H42N2O3S
Molecular Weight: 414.66
Molecule Type: Small molecule
Associated Items:
ID: ALA3979715
Max Phase: Preclinical
Molecular Formula: C22H42N2O3S
Molecular Weight: 414.66
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: OCCCCCCCCCCCCCCCC/N=C1/SC[C@H]2[C@H](O)[C@@H](O)CN12
Standard InChI: InChI=1S/C22H42N2O3S/c25-16-14-12-10-8-6-4-2-1-3-5-7-9-11-13-15-23-22-24-17-20(26)21(27)19(24)18-28-22/h19-21,25-27H,1-18H2/b23-22+/t19-,20-,21-/m0/s1
Standard InChI Key: FAQKUJNDGVUWBQ-HASDJUPYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 414.66 | Molecular Weight (Monoisotopic): 414.2916 | AlogP: 3.95 | #Rotatable Bonds: 16 |
Polar Surface Area: 76.29 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.33 | CX Basic pKa: 7.21 | CX LogP: 4.60 | CX LogD: 4.38 |
Aromatic Rings: 0 | Heavy Atoms: 28 | QED Weighted: 0.33 | Np Likeness Score: 0.42 |
1. Mena-Barragán T, García-Moreno MI, Nanba E, Higaki K, Concia AL, Clapés P, García Fernández JM, Ortiz Mellet C.. (2016) Inhibitor versus chaperone behaviour of d-fagomine, DAB and LAB sp(2)-iminosugar conjugates against glycosidases: A structure-activity relationship study in Gaucher fibroblasts., 121 [PMID:26361824] [10.1016/j.ejmech.2015.08.038] |
Source(1):